Skip to Content


In the US, Paricalcitol (paricalcitol systemic) is a member of the drug class vitamins and is used to treat Secondary Hyperparathyroidism.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Analogue of calcitriol (active form of vitamin D)

Treatment of secondary hyperparathyroidism

Chemical Name

(7E,22E)-19-nor-9,10-secoergosta-5,7,22-triene-1α,3β,25-triol (WHO)

Foreign Names

  • Paricalcitolum (Latin)
  • Paricalcitol (German)
  • Paricalcitol (French)
  • Paricalcitol (Spanish)

Generic Names

  • Paricalcitol (OS: USAN, JAN)
  • 19-Nor-1-α-25-Dihydroxyvitamin D₂! (IS)
  • ABT 358 (IS: Abbott)
  • Compound 49510 (IS)
  • Paricalcitol (PH: USP 38)

Brand Names

  • Caltopar
    Sandoz, Croatia (Hrvatska)
  • Palikalex
    Rivero, Argentina
  • Paricalcitol Accord
    Accord, Netherlands
  • Paricalcitol Fresenius
    Fresenius Kabi, Bulgaria; Fresenius Medical Care, Poland; Fresenius Medical Care, Portugal
  • Paricalcitol HEXAL
    Hexal, Germany
  • Paricalcitol Hospira
    Hospira, Portugal
  • Paricalcitol SUN
    Sun Pharmaceutical Industries Europe B.V., Netherlands
  • Paricalcitol Teva
    Teva, Czech Republic; Teva Pharma, Portugal; Teva Pharmaceuticals, Poland
  • Paricalcitol-ratiopharm
    ratiopharm, Germany
  • Pasonican
    Glenmark, Netherlands
  • Porontazin
    Regiomedica, Netherlands
  • Rextol
    Rafarm, Georgia
  • TevaPariVit
    Teva, Bulgaria
  • Velpar
    Velka, Greece
  • Zemplar
    2care4, Norway; Abbott, Argentina; Abbott, Australia; Abbott, Bulgaria; Abbott, Czech Republic; Abbott, Ecuador; Abbott, Indonesia; Abbott, Malta; Abbott, Oman; Abbott, Romania; Abbott, Serbia; Abbott, Taiwan; Abbott, United States; Abbott Laboratories, Lithuania; Abbott Laboratories de Chile, Chile; AbbVie, Austria; AbbVie, Switzerland; AbbVie, Germany; AbbVie, Denmark; AbbVie, United Kingdom; AbbVie, Greece; AbbVie, Hong Kong; AbbVie, Croatia (Hrvatska); AbbVie, Hungary; AbbVie, Ireland; AbbVie, Italy; AbbVie, Latvia; AbbVie, Netherlands; AbbVie, Norway; AbbVie, Sweden; AbbVie, Singapore; AbbVie, Turkey; ABBVIE BIOPHARMACEUTICALS, Israel; Abbvie Farmacéuticos, Mexico; AbbVie Inc., Bosnia & Herzegowina; AbbVie Polska, Poland; AbbVie S.r.L., Slovakia; Aesica Queenborough LTD, Serbia; Eureco-Pharma, Netherlands
  • Zemplar Soft
    AbbVie, Greece
  • Zilidor
    Demo, Greece


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.